Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells
Zhu Wang(ShenZhen People’s Hospital), Franky Leung Chan(Chinese University of Hong Kong)
Cited by 26
Related Papers
Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells
|Proceedings of the National Academy of Sciences|2012|175
Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation
|Chinese Medicine|2019|137
Nuclear receptor ERRα contributes to castration-resistant growth of prostate cancer via its regulation of intratumoral androgen biosynthesis
|Theranostics|2020|30
Natural killer cells strengthen antitumor activity of cisplatin by immunomodulation and ameliorate cisplatin-induced side effects
|International Urology and Nephrology|2023|7